EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin‐10 promoter polymorphisms and haplotypes in patients with Guillain–Barré syndrome

Shoma Hayat iD, Asaduzzaman Asad iD, Moriam Akter Munni, Md Abu Jaher Nayeem iD, Md Golam Mostafa iD, Israt Jahan, Md Zakir Hossain Howlader, Quazi Deen Mohammad, Zhahirul Islam iD

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.51939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Shoma Hayat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Gut-Brain Axis, Infectious Diseases Division (IDD), icddr,b, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome, Interleukin-10. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Interleukin‐10 (IL‐10) is a multifunctional cytokine that exerts both pro‐ and anti‐inflammatory effects on the immune system as well as in the pathogenesis of Guillain–Barré syndrome (GBS). We investigated whether the three common polymorphisms ‐1082 G/A(rs1800896), ‐819 C/T(rs1800871), and ‐592 C/A(rs1800872) in the promoter region of IL‐10 have any influence on the susceptibility, severity, and clinical outcome of GBS.

Methods

IL‐10 promoter polymorphisms were investigated in 152 patients with GBS and 152 healthy controls from Bangladesh using polymerase chain reaction and restriction fragment length polymorphism (PCR‐RFLP), and allele‐specific oligonucleotide‐PCR (ASO‐PCR). Haplotype patterns and frequencies were analyzed using Heatmaply R‐package, chi‐square, and Fisher's exact test. The serum level of IL‐10 was measured through enzyme‐linked immunosorbent assays. p ‐values < 0.05 were considered statistically significant.

Results

IL‐10 promoter polymorphisms ‐1082 G/A, ‐819 C/T, and ‐592 C/A were not associated with GBS susceptibility. The homozygous ‐819 TT genotype showed a tendency with susceptibility ( p = 0.029; p c = 0.08) and was prevalent in axonal variants of GBS compared to demyelinating subtypes and controls ( p = 0.042, OR = 8.67, 95% CI = 1.03–72.97; p c = 0.123 and p = 0.005, OR = 4.2, 95% CI = 1.55–11.40; p c = 0.015, respectively). Haplotype analysis revealed 19 patterns of genotypes and high IL‐10 expression haplotype combinations (GCC/GTA, GCC/ATA, and GCC/GCA) may have influence on disease severity ( p = 0.026; p c = 0.078). Serum expression of IL‐10 was elevated in GBS patients ([GBS, 12.16 ± 45.71] vs. [HC, 0.65 ± 5.17] pg/mL; p = 0.0027) and varied with disease severity ([severe‐GBS, 15.25 ± 51.72] vs. [mild‐GBS, 3.59 ± 19.79] pg/mL, p = 0.046).

Interpretation

The ‐819 TT genotypes influence axonal GBS, and high frequency of IL‐10 expression haplotype combination with elevated serum IL‐10 may play an important role in disease severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guillain-Barre SyndromeInterleukin-10HumansGenetic Predisposition to DiseaseHaplotypesPolymorphism, Single NucleotidePromoter Regions, Genetic

Substanzen

Interleukin-10IL10 protein, human

Autor:innen und Institutionen

  • Laboratory of Gut-Brain Axis, Infectious Diseases Division (IDD), icddr,b, Dhaka, Bangladesh.
  • Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
  • National Institute of Neurosciences and Hospital, Dhaka, Bangladesh.

ORCID-Profile: Shoma Hayat, Asaduzzaman Asad, Md Abu Jaher Nayeem, Md Golam Mostafa, Zhahirul Islam

Zitieren

APA

Hayat, S., Asad, A., Munni, M. A., Nayeem, M. A. J., Mostafa, M. G., Jahan, I., Howlader, M. Z. H., Mohammad, Q. D., & Islam, Z. (2024). Interleukin‐10 promoter polymorphisms and haplotypes in patients with Guillain–Barré syndrome. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51939

Vancouver

Hayat S, Asad A, Munni MA, Nayeem MAJ, Mostafa MG, Jahan I, et al. Interleukin‐10 promoter polymorphisms and haplotypes in patients with Guillain–Barré syndrome. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.51939

BibTeX
@article{Hayat2024,
  author = {Hayat, Shoma and Asad, Asaduzzaman and Munni, Moriam Akter and Nayeem, Md Abu Jaher and Mostafa, Md Golam and Jahan, Israt and Howlader, Md Zakir Hossain and Mohammad, Quazi Deen and Islam, Zhahirul},
  title = {Interleukin‐10 promoter polymorphisms and haplotypes in patients with Guillain–Barré syndrome},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.51939}
}
Kostenlos starten →